Summary
Introduction
Studies with cultured normal human fibroblasts (Goldstein & Brown, 1974 Kawahara, 1974) or peripheral blood lymphocytes (Fogelman, Edmond, Seager & Popjak, 1975) have shown that these cells bind, internalize and degrade serum low-density lipoprotein (LDL). After binding and uptake, LDL is transported to lysosomes where the apoprotein is degraded and the cholesterol, among other lipids, is released. The liberated unesterified cholesterol modulates a series of events which limit further increase in its own intracellular concentration, i.e., the suppression of the key enzyme in cholesterol synthesis, 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase, the activation of a cholesterol esterifying enzyme and the suppression of the synthesis of proteins forming the receptor sites for surface binding of LDL.
A critical step in this process is the initial binding of LDL, via its protein moiety, apolipoprotein B (apo B) , to high-affinity cell-surface receptors. Thus where such receptors appear to be absent or defective, as in cells from cases of homozygous familial hypercholesterolaemia, there is a failure of LDL binding and of modulation of the intracellular processes described above (Goldstein & Brown, 1974 Goldstein, Dana, Brunschede & Brown, 1975) .
The nature of the important interaction between LDL and its specific cell-surface receptor has been studied by using a 1251-labelled LDL binding assay at 4OC, at which temperature the internalization of LDL is inhibited (Goldstein & Brown, 1974) . This procedure is sensitive but suffers from the drawback that, above certain concentrations of LDL, non-specific low-amnity binding, as well as the specific high-affinity binding, contributes to the total amount of 1251-labelled LDL bound by the cells. As an alternative, therefore, we have adapted an immunological technique (known to detect membrane antigens and surface-bound material only) to detect LDL receptors by 'rosette' formation of erythrocytes coated with LDL around the cells of certain lymphoid cell lines, as described below. This method was compared with an lZ51-labelled LDL binding procedure used on similar lymphoid lines by others (Ho, Brown, Kayden & Goldstein, 1976) .
Materials and methods

Lymphoblastoid cell lines
The EB, line was obtained from Flow Laboratories, Irvine, Scotland. The MOLT-4 and DUN lines were obtained respectively from Dr N. Ling N-2-hydroxyethylpiperazine-N1-2-ethane sulphonic acid (HEPES)/I, 10% foetal calf serum, 1% L-glutamine, penicillin (100 p/ml) and streptomycin (50 p/ml). Fresh medium was added regularly to maintain the cell concentration at about 1-2 x lo6 celldml.
Lipoprotein-deJicient foetal calf serum
The background density of heat inactivated foetal calf serum was adjusted to approximately 1.24 g/ml by the addition of 33 g of sodium bromide/100 ml of serum. The serum lipoproteins were then separated from other serum proteins by ultracentrifugation in a Beckman L2-65 ultracentrifuge (50 Ti rotor; 40000 rev./ min for 40 h at 10°C). The supernatant lipoproteins were discarded and the infranate was pooled and dialysed exhaustively against 0.875% sodium chloride at 4OC. Total cholesterol concentration in the lipoprotein-deficient serum was estimated by gas-liquid chromatography to be between 5 and 15 pg/ml.
Serum lipoproteins
LDL was prepared from a pool of human serum by precipitation with dextran sulphate and ultracentrifugation (Oncley, Walton & Cornwell, 1957) . The LDL was dialysed against 0.875% sodium chloride, 0.01% EDTA, pH 7.2, and stored at 4OC. LDL prepared by zonal ultracentrifugation in a density gradient (Havel, Eder & Bragdon, 1955) and reflotation by centrifugation in a medium of density 1.063 g/ml, or isolated after precipitation with sodium phosphosphotungstate (Burstein & Scholnick, 1972) , was compared with LDL prepared by dextran sulphate. All three preparations behaved identically in inhibiting rosette formation (see below). Very-low-density lipoprotein (VLDL), highdensity lipoprotein (HDL) and lipoprotein-free human serum were prepared from normal human serum by differential ultracentrifugation (Havel et al., 1955) , dialysed and stored as for LDL. The protein concentrations of the preparations were determined by the Folin-Lowry technique with human serum as standard (Lowry, Roseborough, Farr & Randall, 195 1) .
Iodination of LDL
LDL was iodinated with sodium [1Z511iodide (IMS 30, The Radiochemical Centre, Amersham, Bucks., U.K.) by using iodine monochloride (Shepherd, Bedford, Morgan & Scott, 1976) . The 1251-labelled LDL was separated from unbound iodine by centrifugal desalting (Hawker, 1974) and stored at 4°C. The iodine monochloride concentration was adjusted to give a labelling efficiency of between 25 and 35%. Between 90 and 95% of the radioactivity associated with the LDL was precipitated by trichloroacetic acid.
Induction of high-afinity LDL cell-surface receptors
Cells from stock cultures were harvested by gentle centrifugation, washed once in Sorensen's phosphate-buffered sodium chloride solution (0.15 mol/l; saline) and resuspended to their original volume with culture medium supplemented with lipoprotein-deficient serum. The cells were incubated at 37OC for between 36 and 48 h. Fresh medium was added after 24 h.
The 1251-labelled LDL surface-binding assay
The surface binding of 1Z51-labelled LDL was determined by a modification of the method of Ho et al. (1976) . Cells incubated in medium supplemented with lipoprotein-deficient serum or foetal calf serum were collected by gentle centrifugation, washed twice in phosphate-buffered saline and taken up in 2% bovine serum albumin in Hanks balanced salt solution to a concentration of 2-3 x lo7 celldml. Labelled LDL was diluted in bovine serum albumin/Hanks solution to a specific radioactivity of 25-100 c.p.m./ng of LDL protein and filtered through a 0.45 pm Millipore filter just before use. For the binding assay, 100 p1 of the cell suspension, pre-cooled to O°C for at least 30 min, and 100 pl of the 1Z51-labelled LDL, similarly pre-cooled, at the appropriate concentration, were mixed in 5 mm x 90 mm glass tubes in an ice bath and left for 1 h with gentle remixing every 15 min. After binding, the cells were centrifuged at 4OC, the supernatant was discarded and the pellet washed twice in cold bovine serum albumin/Hanks solution and once in cold Hanks solution. Finally, the pellet was resuspended in approximately 50 pl of cold Hanks solution and layered on to 300 pl of the bovine serum albumin/Hanks solution in microcentrifuge tubes and centrifuged (Beckman microcentrifuge; 12 000 rev./ min at 4OC for 5 min). The cell pellet was cut from the bottom of the tube and transferred to polypropylene tubes containing 5 0 0 pl of sodium hydroxide (0.1 mmol/l) plus 1% sodium dodecyl sulphate. The 12sI-labelled LDL bound was determined in a well-type gamma-counter and after an overnight incubation at 37OC, a portion of the dissolved cell pellet was taken for protein determination.
Passive sensitization of human erythrocytes with LDL
Fresh human group 0 cells were coated with LDL by using chromic chloride essentially as described for the immunoglobulin coating of erythrocytes by Ling, Bishop & Jefferis (1977) . The cells were washed twice with phosphatebuffered saline and resuspended in diluent (2% bovine serum albumin/Hanks solution) to a 2.5% suspension. The efficiency of coating was tested by agglutination with rabbit anti-(human LDL). Cells agglutinated to a titre of 1/4000 were accepted as satisfactorily coated.
The LDL-coated erythrocyte rosette test
All procedures were carried out at room temperature. The lymphoblastoid cells, cultured in medium supplemented with either foetal calf serum or lipoprotein-deficient serum, were collected by gentle centrifugation, washed once in phosphate-buffered saline and then resuspended in the erythrocyte diluent to a concentration of 2-4 x 10" cells/ml. For rosetting, 50 pl of cells, 100 p1 of LDL-coated erythrocytes and 100 pl diluent were mixed in 9 mm x 50 mm round-bottomed glass tubes and then centrifuged at approximately 100 g for 3 min. Diluent (200 pl) and 50 pl of 0.2% Toluidine Blue in 0.85% sodium chloride solution were then added and the cell pellet was gently resuspended by inverting the tube 10 times. A portion of the suspension was carefully run into a specially constructed slide chamber and the cells were allowed to settle for 5 min. The proportion of cells rosetting was determined by counting between 200 and 300 lymphoblastoid cells. A cell was scored as a rosette if three or more erythrocytes were found adhering to it. Non-viable cells, which stained very dark blue, were discounted.
The rosette-inhibition test
For the inhibition test, 100 pl of inhibitor was added instead of the diluent in the first step of the rosette test.
Trypsinization of the cell-surface receptors
Trypsin (Sigma type IX hog pancreas) was dissolved in phosphate-buffered saline and assayed for activity by hydrolysis of N-benzoylarginine ethylester (BAEE) as described by Schwert & Tanaka (1955) . To study the effect of trypsin on LDL-mediated rosetting, cells were first cultivated in lipoprotein-deficient medium as before, washed twice and suspended in Hanks solution to a concentration of 10' celldml. Volumes of cells (100 pl) were incubated for 15 min at 37OC with equal volumes of trypsin at various concentrations. The reaction was then inhibited by the addition of 500 ,ul of 2% bovine serum albumin/Hanks solution and the cells were washed twice and resuspended in 200 pl of the same solution. Portions (50 pl) were taken for rosette testing.
To follow the regeneration of the LDL receptors after trypsin treatment, 2 ml of cells ( 107/ml) were treated as above with sufficient trypsin to reduce the level of rosetting by about 50%. The washed cell pellet was reconstituted to twice its original volume with lipoprotein-deficient medium and incubated at 37°C. Portions were withdrawn at regular intervals and used directly in the rosette test. As a control, cells were incubated with phosphate-buffered saline in place of trypsin.
ModiJication of LDL
LDL was modified as described by Mahley, Innerarity, Pitas, Weisgraber, Brown & Gross (1977) . Approximately 1 mg of LDL protein in 1 ml of 0.85% sodium chloride/0-01% EDTA solution (pH 7.4) was mixed with 2 ml of 0.15 mol of 1,2-cyclohexanedione/1 in sodium borate (0.2 mol/l) buffer (pH 8.1) and incubated at 35OC for 2 h. The modified LDL was then dialysed overnight at 4°C against 2 litres of 0.85% sodium chloride solution containing 0.01% EDTA (pH 7.4) and used immediately in rosette-inhibition studies. Solutions of untreated and treated LDL were prepared for amino acid analysis as described by Mahley et al. (1977) and the analysis was carried out by Dr J. E. Fox, Department of Chemistry, University of Birmingham.
Results
Characteristics of the cloned lymphoblastoid cell lines
Three well-established cloned lymphoblastoid cell lines were studied ( Table 1 ). The MOLT-4, a line derived from a patient with acute lymphatic leukaemia, is reported to be a T-lymphocyte-like cell (Minowada, Ohuma & Moore, 1974) . The EB, and DUN lines are both derived from B lymphocytes, the former from a patient with Burkitt's lymphoma and the latter from a case of infectious mononucleosis (Evans, Steel & Arthur, 1974) . All the lines grew well under the culture conditions described in the Materials and methods section.
Binding of 1251-labelled LDL to lymphoblastoid cells
After incubation of the DUN line of cells in the lipoprotein-deficient medium for 36-48 h, then exposure to various concentrations of 1251-labelled LDL for 1 h at M 0 C , a four-to five-fold increase in lipoprotein binding was observed over cells grown in the normal foetal calf serum medium (Fig. la) . The amount of lz51-labelled LDL bound by the cells cultured in the foetal calf serum medium appeared to increase linearly with concentration (lower curve in Fig. la) . But the binding of the lipoprotein to cells grown in the lipoprotein-deficient medium appeared to be more complex. In this instance, a high-affinity binding curve, non-linear above 50 
LDL-mediated rosetting
After incubation in the lipoprotein-deficient medium for 36 h, all three cell lines were tested for their ability to rosette with LDL-coated human group 0 erythrocytes. Under the conditions described in the Materials and methods section, both the DUN and the MOLT-4 lines rosetted consistently, producing easily distinguishable, well-formed rosettes (Fig. 2a) MOLT-4 cells which rosetted were high, a wide variation in the amounts (60-95%) was observed between experiments ( Table 2) . This variation was due in part to the variation in the amount achieved of LDL coating of the erythrocytes, i.e. the greater the sensitization of the erythrocytes as measured by the agglutination titre of a monospecific rabbit anti-(human LDL), the higher the proportion of lymphoblastoid cells which rosetted. Unsuccessful or partially successful erythrocyte sensitization drastically reduced or totally abolished rosette formation. The proportion of cells which rosetted was stable at room temperature, little variation being encountered after standing for up to 1 h. There was also no evidence of internalization by phagocytosis of the bound coated erythrocytes over this period, evidence that the ligand interaction between the LDL-coated erythrocytes and the lymphoblastoid cell-surface receptors does not result in the usual sequence of adsorptive endocytosis and lysosomal degradation, and that rosetting is a function of LDLheceptor interaction alone.
Inhibition of rosetting
By EDTA. The requirement for bivalent cations in LDL-mediated rosetting was investigated by inhibition with EDTA. For the test, 2% bovine serum albumin/Hanks solution was replaced by 2% bovine serum albumin in phosphate-buffered saline because the Hanks solution contains relatively high concentrations of CaZ+ (12-6 mol/l) and Mg2+ (9 mol/l). Under these conditions, a relatively low concentration of EDTA (0.4 mol/l) completely inhibited the rosetting by both the DUN and the MOLT-4 cells (Fig. 3) . Thus either CaZ+ or Mgz+ or both are required for rosetting.
By heparin. Heparin (25 000 i.u./ml; Weddel Industries, London) was diluted in the bovine serum albumin/Hanks solution and tested over a range of concentrations for inhibition of the LDL-mediated rosetting. Increasing concentrations of heparin resulted in progressive inhibition of rosetting (Fig. 4) . A heparin concentration of 1000 i.u./ml completely inhibited all rosette formation. By serum lipoproteins. Serum lipoprotein fractions were tested for their ability to inhibit rosetting (Fig. 5) . As expected, both VLDL and LDL proved effective inhibitors with, unexpectedly, VLDL showing a more potent inhibitor activity than LDL (protein weight for weight). Over the same protein concentration range, HDL failed to show any inhibitory activity whatsoever. The lipoprotein protein-concentration range over which LDL inhibited rosette formation compares well with the range within which unlabelled LDL has been demonstrated to inhibit 12SI-labelled LDL binding by the specific high-affinity receptors on other lymphoblastoid cells (Ho et al., 1976) . Thus the sensitivity of the rosette-inhibition test makes it a more than adequate technique for the study of LDL/ receptor interactions.
Other human serum proteins, in the form of lipoprotein-free human serum (hydrated density > 1.25 g/ml) proved totally incapable of inhibitory rosette formation, even at concentrations as high as 10 mg/ml.
By selectively modijied LDL. Treatment of LDL with 1,2-~yclohexanedione (0.1 mol/l) in borate buffer (0.2 mol/l) (pH 8.1) at 35OC has been reported to result in the progressive selective modification of the arginyl residues of the apoprotein (Mahley et al., 1977) . This selective alteration in the basic nature of the apo B protein of LDL reduces progressively its capacity to bind to the specific high-affinity receptor. Such treatment of LDL for 2 h at 35OC totally abolished its ability to inhibit LDL-mediated rosette formation (Fig. 6) . A comparative amino acid analysis of the modified and parent LDL indicated a reduction by 33% in the measurable arginyl residues of the apoprotein after the treatment with cyclohexanedione.
Eflect of trypsin on rosetting
Limited proteolysis of the lymphoblastoid cells by incubation with increasing concentrations of trypsin resulted in a progressive reduction in their rosette-forming ability (Fig. 7) . Excessive proteolysis, either by the additon of high concentrations of trypsin or by prolonged incubation of the cells with the enzyme, led to irreversible aggregation and cell death.
Regeneration of rosetting after trypsinization
Proteolytic conditions which reduced rosetting to 3040% of its original amount did not affect the viability of the cells to any great degree, and on resuspension in lipoprotein-deficient medium they recovered well. The regeneration time of the rosette-forming capacity of the cell was followed after such treatment (Fig. 8) . Although the rate of regeneration varied from experiment to experiment depending on the viability of the cells, half regeneration times for LDL-mediated rosetting by both cell lines were observed to be between 60 and 180 min. 
Discussion
From these results, the properties of LDL receptors, as defined by the 'rosette' technique now described, appear to be identical with those elicited by using lZ51-labelled LDL at 4OC. For example, LDL binding: (i) requires Ca2+ or Mgz+ (Goldstein & Brown, 1974) ; (ii) is interfered with by heparin (Goldstein, Basu, Brunschede & Brown, 1976) ; (iii) is sensitive to proteolysis (Brown 8z Goldstein, 1975) but (iv) is restored after removal of receptors by proteolytic enzymes with a half-time for regeneration of the receptors of 1-3 h (Curtiss & Edgington, 1978) ; (v) is inhibited by the apo B-containing lipoproteins, LDL and VLDL, but not by HDL at plasma concentrations or by other plasma proteins (Goldstein & Brown, 1974) ; (vi) is reduced or abolished if the arginyl residues of the apoprotein of LDL are modified (Mahley et al., 1977) . As compared with the use of radioisotopically labelled LDL, the 'rosette' technique presents certain advantages. These include: (a) economy and simplicity in not requiring the purchase of radioisotopes nor the equipment for labelling, handling and counting of radioactivity; (b) greater specificity for surface binding since the LDL is presented in a form which cannot be interiorized; (c) the latter feature also obviates careful temperature control since only surface binding occurs even at room temperature and is stable, for a given level of LDL in the environment, at that temperature. On the other hand, the 'rosetting' technique, although being unaffected by non-specific (low-afEnity) uptake occurring concurrently with specific surface binding of LDL, is unsuitable for studying the former kind of interiorization of lipoprotein where it alone occurs. In such circumstances it is still necessary to resort to the use of isotopically labelled LDL or other techniques to confirm the actual entry of LDL into cells.
Our observations confirm those of Ho et al. (1976) , which established that LDL binding to high-affinity specific receptors is demonstrable in some lymphoblastoid cell lines as well as in freshly isolated lymphocytes and fibroblasts. The use of additional cell lines to the ones previously studied by Ho et al. (1976) allows the preliminary suggestion that the presence of the LDL receptor is unrelated to whether the cell line originates from B or T cells and is also independent of the presence of certain other membrane receptors (e.g. the 'E' and 'Fc' receptors). However, a study in detail of the relation between the occurrence of the LDL receptor and other surface markers on these cells would require the investigation of a much larger range of cell lines than we have used.
The absence or defective behaviour of LDL receptors has previously been reported only as a genetically mediated abnormality in cases of familial hypercholesterolaemia. But we have been unable to detect high-affinity surface binding of LDL, by either rosetting or by 1251-labelled LDL uptake, in EB, cells. There is no reason to suppose that this cell line originated from a patient with homozygous familial hypercholesterolaemia. In contrast, it is well established that, after viral transformation, chemical mutagen treatment or neoplastic stimulation, lymphoid cell lines may show the loss of certain membrane characteristics on continuous culture, but the retention of others.
In this connection, it is noteworthy that the MOLT-4 cell line, when first established, was reported to form rosettes with erythrocytes from a number of non-human species via the Tlymphocyte specific 'E' receptor (Minowada et al., 1974) . Although we have not detailed our experiments in the Results section, it is worth noting here that, in our laboratory, the MOLT-4 line consistently failed to express 'E' receptor rosetting against neuraminidase-treated sheep erythrocytes (Galili & Schlesinger, 1974) , which rosetted well against some freshly isolated peripheral blood lymphocytes (presumptive T cells). On the other hand, the MOLT-4 line showed good rosetting capacity against LDLcoated erythrocytes (Table 2) .
Attention is drawn to this variable expression, on long-term culture, of LDL receptors in cell lines which we have encountered since it is necessary to ensure that such behaviour is not erroneously interpreted as evidence of the familial hypercholesterolaemia abnormality in other cell lines maintained in culture over long periods.
